Tenax Therapeutics (TENX) Change in Cash (2016 - 2017)
Historic Change in Cash for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to -$159073.0.
- Tenax Therapeutics' Change in Cash fell 10171.53% to -$159073.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$8.4 million, marking a year-over-year decrease of 23244.64%. This contributed to the annual value of $85.1 million for FY2024, which is 100927.23% up from last year.
- According to the latest figures from Q4 2017, Tenax Therapeutics' Change in Cash is -$159073.0, which was down 10171.53% from -$469803.0 recorded in Q3 2017.
- In the past 5 years, Tenax Therapeutics' Change in Cash ranged from a high of $9.3 million in Q4 2016 and a low of -$36.4 million during Q3 2014
- In the last 5 years, Tenax Therapeutics' Change in Cash had a median value of -$837838.0 in 2016 and averaged -$2.4 million.
- The largest annual percentage gain for Tenax Therapeutics' Change in Cash in the last 5 years was 66490.99% (2014), contrasted with its biggest fall of 120541.88% (2014).
- Quarter analysis of 5 years shows Tenax Therapeutics' Change in Cash stood at $2.5 million in 2013, then plummeted by 398.93% to -$7.6 million in 2014, then skyrocketed by 43.75% to -$4.3 million in 2015, then skyrocketed by 316.9% to $9.3 million in 2016, then plummeted by 101.72% to -$159073.0 in 2017.
- Its Change in Cash was -$159073.0 in Q4 2017, compared to -$469803.0 in Q3 2017 and -$4.8 million in Q2 2017.